Webcast

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL is Associate Professor for the Department of Family & Community Medicine at the Lewis Katz School of Medicine at Temple University and Temple University Hospital, and Chief Quality Officer for the Temple Faculty Practice Plan. She is an attending physician at Temple University Hospital (Philadelphia, PA) and Christiana Care Health System (Wilmington, DE). Dr. Savoy graduated from the University of Maryland School of Medicine in 2002, completed Family Medicine Residency Program at the Crozer-Keystone Family Medicine Residency Program (Springfield, PA) in 2005, and graduated from the University of North Carolina Chapel Hill Gillings School of Global Public Health in 2008 with a Master’s degree in Public Health in Public Health Leadership with a focus on Public Health Practice. She is certified by the American Board of Family Medicine, the Certifying Commission in Medical Management, and is a Fellow of the Advisory Board Company.

Dr. Huhn is an infectious disease specialist and is currently the Senior Director for HIV Services at Cook County Health and The Ruth M. Rothstein CORE Center, an associate professor of medicine at Rush University Medical Center, where he serves as the associate director for the joint Rush University/Cook County Health Infectious Diseases Fellowship Program. He lectures regularly at the University of Illinois, Chicago, School of Public Health, where he holds an adjunct assistant professor position. Since November 2020, Dr. Huhn has been the Covid-19 vaccination coordinator for Cook County Health. He received his medical degree from Tulane University, where he earned a concomitant Master of Public Health and Tropical Medicine, trained at Duke University in Internal Medicine, and completed his infectious diseases fellowship at Rush University Medical Center in 2005.

From 2002 to 2004, Dr. Huhn was based at the Illinois Department of Public Health as the Epidemic Intelligence Service Officer with the CDC. His research activities include HIV and viral hepatitis, Covid-19, outbreak investigations, infectious disease surveillance, and risk analysis, and he has published over 65 articles in peer-reviewed literature. He was the Principal Investigator in recently completed, NIH-funded, R01 grant examining pre-exposure prophylaxis adherence for HIV prevention and has been the Principal Investigator for several pharmaceutical-sponsored clinical trials in HIV, hepatitis C, and Covid-19.

In addition Dr. Huhn has developed several investigator-initiated studies examining novel therapeutic, diagnostic, and patient retention interventions in HIV, viral immunopathogenesis, and hepatitis C-associated liver fibrosis. Dr. Huhn also mentors and supervises postgraduate trainees in HIV, viral hepatitis-related longitudinal and retrospective database, and survey studies. Dr. Huhn published a book, serving as the editor for a new series in HIV through Oxford University Press in 2020, is the therapeutic advisor for the Simply Speaking HIV Management CME series since 2015, has been a content faculty expert on several other CME programs, and is a frequent teacher and lecturer across the country.

Peter Chen obtained a BS in Electrical Engineering from the University of Texas, his MD from Baylor College of Medicine, and then trained in Internal Medicine at UT Southwestern. Subsequently, he did his fellowship in Pulmonary and Critical Care Medicine at the University of Washington, where he also started basic research training in lung biology. Working with his mentor, Bill Parks, he unraveled mechanisms by which the lung epithelium interacts with the matrix to facilitate lung injury and repair. He started his academic career as an Assistant Professor at the University of Washington, where he continued to establish himself as a physician-scientist focused on understanding mechanisms of acute lung injury with an overarching theme in studying lung mucosal immunity.

Dr. Chen rose to the rank of Associate Professor at the University of Washington before being recruited by Paul Noble to Cedars-Sinai in 2013, to become the Director of the Division of Pulmonary and Critical Care Medicine. He currently is a Professor of Medicine and Biomedical Sciences and has been active in mentoring trainees within the Women’s Guild Lung Institute, which has led to multiple fellowship, and career development awards, and also a T32 institutional training grant. He also established the Physician-Scientist Training Program within the Internal Medicine Residency, which is focused on developing the next generation of physician-scientists.

During his time at Cedars-Sinai, he has transformed the Division by expanding the clinical care programs and mirroring it with a world-class research program. Accordingly, the Division has had a quick rise in the US News and World Report rankings to #3 in 2020. Since 2013, the Division of Pulmonary and Critical Care has grown from 8 MDs to currently 16 MDs and 8 PhDs. In this time, the Division has developed state-of-the-art clinical programs for the care of all respiratory diseases such as for interstitial lung disease, COPD, asthma, and pulmonary vascular disease. Most recently, a post-COVID clinic was started to serve the growing number of patients seeking care for long-term consequences after infection. Furthermore, the Women’s Guild Lung Institute has developed into a premier pulmonary research institute housing internationally recognized researchers that conduct basic, translational, and clinical research in interstitial lung disease, pulmonary vascular disease, acute lung injury, COVID-19, cystic fibrosis, and regeneration.

Dr. Chen has been highly accomplished as a physician-scientist that has been continually NIH-funded since fellowship. He was published in some of the top clinical and basic science journals including the New England Journal of Medicine, JAMA, American Journal of Respiratory and Critical Care Medicine, JCI Insight, Cell Reports, among many others. He was awarded the Jo Rae Wright Award for Outstanding Science by the American Thoracic Society (ATS) in 2013, which is a highly competitive award presented to a rising star within this international respiratory society of 16,000+ members. He has served on study sections for the NIH, VA merit, and American Heart Association, is on the editorial board of the American Journal of Respiratory Cellular and Molecular Biology and has held several leadership positions in the ATS.

During the COVID pandemic, Dr. Chen has taken a prominent role in both the clinical and research aspects of this disease. He is a frontline clinician and has been caring for COVID patients in the ICU since the beginning of the pandemic. As the Director of the Division of Pulmonary and Critical Care, he has coordinated the ICU response during the pandemic and worked closely with the Cedars-Sinai leadership to expand the ICU capacity to meet the needs of the growing COVID-19 census. Finally, he was on the forefront of the research in understanding the pathogenesis of the disease and also developing novel therapies for COVID-19 patients. He has been invited by numerous international societies to talk about his work in COVID-19, sits on the California COVID-19 Academic Advisory Board, and has been featured in several media stories locally and nationally such as in the New York Times.

Dr. Stanford is an Associate Professor of Medicine and Pediatrics who practices and teaches at Massachusetts General Hospital (MGH)/ Harvard Medical School (HMS) as one of the first fellowship-trained obesity medicine physicians worldwide. She is among the most highly cited obesity medicine physician-scientists with over 170 peer-reviewed publications. Dr. Stanford received her BS and MPH from Emory University as an MLK Scholar, her MD from the Medical College of Georgia School of Medicine as a Stoney Scholar, her MPA from the Harvard Kennedy School of Government as a Zuckerman Fellow in the Harvard Center for Public Leadership and her executive MBA as a merit-based scholarship recipient from the Quantic School of Business and Technology. She completed her Obesity Medicine & Nutrition Fellowship at MGH/HMS after completing her internal medicine and pediatrics residency at the University of South Carolina. She has served as a health communications fellow at the Centers for Disease Control and Prevention and as a behavioral sciences intern at the American Cancer Society. Upon completing her MPH, she received the Gold Congressional Award, the highest honor Congress bestows upon America’s youth.

Dr. Stanford has completed a medicine and media internship at the Discovery Channel. An American Medical Association (AMA) Foundation Leadership Award recipient in 2005 and an AMA Paul Ambrose Award for national leadership among resident physicians in 2009, she was selected for the AMA Inspirational Physician Award in 2015. The American College of Physicians (ACP) selected her as the 2013 Joseph E. Johnson Leadership Award recipient, and the Massachusetts ACP selected her for the Young Leadership Award in 2015. She is the 2017 recipient of the HMS Amos Diversity Award and the Massachusetts Medical Society (MMS) Award for Women’s Health. In 2019, she was selected as the Suffolk District Community Clinician of the Year for the Reducing Health Disparities Award for MMS. She was chosen for The Obesity Society Clinician of the Year in 2020. In 2021, she was awarded the MMS Grant Rodkey Award for her dedication to medical students and the AMA Dr. Edmond and Rima Cabbabe Dedication to the Profession Award, which recognizes a physician who demonstrates active and productive improvement to the profession of medicine through community service, advocacy, leadership, teaching, or philanthropy. She is the 2021 Recipient of the Emory Rollins School of Public Health Distinguished Alumni Award. In 2022, the National Academy of Medicine selected her as a Scholar in Diagnostic Excellence. She was named to the 2025 Dietary Guidelines Advisory Committee by the US Department of Health and Human Services (HHS) and Agriculture (USDA).

Dr. Ken Fujioka is the director of the Nutrition and Metabolic Research Center and the Center for Weight management at the Scripps Clnic in La Jolla, California. His time is divided equally between clinical research and clinical practice. Dr. Fujioka’s research includes diets, medications, bariatric surgery, medical devices, web based weight loss programs, and outcomes in obesity treatment. The Nutrition and Metabolic Research Center has completed over 100 clinical trials in obesity related areas. The Center for Weight Management is a referral based multispecialty center that includes endocrinologists, surgeons, psychologist, dietitians, exercise physiologist, and nurse practitioners. The multispecialty clinic sees over a 1,000 patients a month and is a recognized Center of Excellence treating all forms of obesity, morbid obesity, and eating disorders. Dr. Fujioka has also worked for the Medical Board for the state of California as an expert witness. In 1997 he was asked to define the standard of care in the treatment of obesity. He has published original research, as well as chapters of books and reviews. Additionally, he has worked with multiple government agencies and pharmaceutical companies on drug development and use in clinical practice.

Robert Kushner is Professor of Medicine and Medicine Education at Northwestern University Feinberg School of Medicine, and Director of the Center for Lifestyle Medicine in Chicago, IL, USA. After finishing a residency in Internal Medicine at Northwestern University, he went on to complete a post-graduate fellowship in Clinical Nutrition and earned a master’s degree in Clinical Nutrition and Nutritional Biology from the University of Chicago. Dr. Kushner is past-President of The Obesity Society (TOS), the American Society for Parenteral and Enteral Nutrition (ASPEN), the American Board of Physician Nutrition Specialists (ABPNS), and a founder and past-Chair of the American Board of Obesity Medicine (ABOM). He was awarded the 2016 Clinician-of-the-Year Award by The Obesity Society, the John X. Thomas, Jr. Best Teachers of Feinberg Award at Northwestern University Feinberg School of Medicine in 2017, and the Friend Award by the Academy of Nutrition and Dietetics Weight Management Group in 2020.

Dr. Kushner has authored over 250 original articles, reviews, books and book chapters covering medical nutrition, medical nutrition education, and obesity, and is an internationally recognized expert on the care of patients who are overweight or obese. He is author/editor of multiple books including Nutrition and Bariatric Surgery (CRC Press, 2015), “Lifestyle Medicine: A Manual for Clinical Practice” (Springer, 2016), Obesity Medicine, Medical Clinics of North America (Elsevier, 2018), Creating a Lifestyle Medicine Center (Springer, 2020), and “Primary Care: Evaluation and Management of Obesity” (Wolter Kluwer, 2022). His latest popular book is “Six Factors to Fit: Weight Loss that Works for You!” (Eat Right Press, 2020). Dr. Kushner’s research interests include medical and obesity education, and lifestyle and pharmacological approaches to obesity.

Dr. Barnes is a cardiologist and vascular medicine specialist at the University of Michigan Health System. His clinical and research interests center around the care of patients with thrombotic conditions and/or who require the use of anticoagulant medications. He is also a health services researcher with expertise in implementation science. He serves as co-director for the Michigan Anticoagulation Quality Improvement Initiative (MAQI2) and is currently funded by NHLBI and AHRQ to improve the delivery of anticoagulation care. He serves in leadership roles with numerous organizations, including the Anticoagulation Forum, American College of Cardiology, and American Heart Association.

Dr. Piazza is an Associate Professor of Medicine at Harvard Medical School, and serves as faculty in the Cardiovascular Division at Brigham and Women’s Hospital. Dr. Piazza received his medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts, and completed a residency in internal medicine, general cardiology fellowship, an advanced cardiovascular imaging fellowship, and served as chief medical resident at Beth Israel Deaconess Medical Center in Boston. He also completed a National Heart Lung and Blood Institute- sponsored advanced fellowship in vascular medicine at Brigham and Women’s Hospital. Dr. Piazza’s research interests include the epidemiology, pathophysiology, diagnosis, treatment, and prevention of venous thromboembolism, thrombophilia-associated infertility, computerized decision support to improve cardiovascular outcomes, as well as stroke prevention in atrial fibrillation.

Terri Weaver is dean emerita at the University of Illinois Chicago College of Nursing. She is recognized nationally and internationally for her research on the effect of daytime sleepiness on daily behaviors and assessment of treatment outcomes. Her research career has been honored with many accolades, including induction into the Sigma Theta Tau International Nurse Researcher Hall of Fame. Distinguished as a leader in nursing education, Dr. Weaver was also elected in 2017 to a two-year term on the board of directors of the American Association of Colleges of Nursing. In 2018, she was named to the first class of fellows of the American Thoracic Society.

As a researcher, Dr. Weaver has been supported with funding from the National Institutes of Health, the National Heart, Lung and Blood Institute and the National Institute of Nursing Research. She has produced two notable disease-specific functional status measures, one for chronic pulmonary disorders and the other for sleep disorders. The latter, the Functional Outcomes of Sleep Questionnaire, has become the gold standard for the evaluation of evaluating the impact of treatments for sleep disorders to improve quality of life and; it has been translated into 51 languages and used internationally in clinical trials.

Dr. Weaver earned her BSN at the University of Pittsburgh and her MSN and PhD from the University of Pennsylvania. She is a fellow of the American Academy of Nursing, where she previously served as a member of its Board of Directors. Additionally, she is the Training and Education Chair for the World Federation of Sleep Research & Sleep Medicine Societies and the former chair of the national board of directors of the American Lung Association. She has also held leadership positions in the American Thoracic Society, the American Academy of Sleep Medicine and the Sleep Research Society.

Yves Dauvilliers, MD, PhD, has held the position of Professor of Neurology and Physiology, and Head of the clinical and research activity of the sleep laboratory at the University of Montpellier, France since 2005.  He is also a member of the research group INSERM U1061, and coordinator of the French National Reference Network for Orphan Diseases (Narcolepsy, Hypersomnia, Kleine-Levin Syndrome). He is author or coauthor of more than 370 papers published in international and national peer-reviewed journals, several book chapters. He has also served as editor of three French books related to sleep medicine.

Dr. Bogan is the President of Bogan Sleep Consultants, LLC. He is also Associate Clinical Professor at the University of South Carolina School of Medicine and Associate Clinical Professor at the Medical University of South Carolina in Charleston, SC.

Dr. Bogan received his bachelor’s degree in chemistry from Wofford College and his MD degree from the Medical University of South Carolina in Charleston. He served his internship and residency, as well as Chief Medical Resident, at the University of Alabama Hospital and Clinics in Birmingham. Thereafter, he completed a fellowship and assistant professorship in the Pulmonary Division of the Department of Medicine at the University of Alabama School of Medicine. He has been certified by the American boards of Sleep Medicine, Internal Medicine, and Pulmonary Diseases.

Dr. Bogan has served as principal investigator on numerous clinical trials in the past and continues to do so now. He has a variety of publications and research interests that focus on topics such as narcolepsy, insomnia, sleep apnea, shift work sleep disorder, restless legs syndrome/periodic limb movement disorder, chronic fatigue/fibromyalgia, and circadian rhythm abnormality.

Dr. Dominic Hegarty practices as a Consultant in Pain Management & Neuromodulation at the Orthopaedic and Spine centre, Mater Private Hospital, Cork.

Dr. Hegarty is recognized as one of Europe’s foremost interventional pain management doctors who is constantly developing new pain techniques to deal with the most complex cases in this area. He is the holder of a doctrine degree (Ph.D., UCC), Master of Science (MSc., Edinburgh) and Fellowships in Ireland, USA (FIPP) and London (Royal College of Medicine) in the area of pain management.

Dominic has specialised in pain management over the last two decades and his expertise in this area is regularly sought by national media and in the High Court on medical legal matters. Dr. Hegarty continues to collaborate with innovation centers and industry in order to provide the best solutions to help individuals who have to deal with chronic pain on a daily basis. He acts as Clinical Lead on Neuromodulation and advisor to Tyndall National Research Institute in base in UCC Cork and also provides consultancy to product development in the med-tech sector in an independent capacity.

In addition to his teaching posts, Dr. Hegarty was awarded the unique position of Honorary Consultant at Guy’s & St. Thomas’ Hospital, London. He co-founded the division of Pain Medicine in the Department of Anaesthesia & Pain Medicine in Cork at University Hospital and South infirmary & Victoria Hospital in Cork, where he served as a consultant for eight years in the Health Service Executive (HSE) before joining the Mater Private Hospital Cork.

Dr. Hegarty is the founder and Clinical director of Pain Relief Ireland, a medical practice focused on integrated pain management options for those with chronic pain. In addition to a busy clinical workload, Dr. Hegarty is President Elect of World Institute of Pain, underlining his ambition to improve pain practice globally.

Christina Ha, MD, FACG, is an Associate Professor with the F. Widjaja Foundation Inflammatory Bowel Immunology Research Institute at Cedars-Sinai She received her BA from Harvard College and her MD from the Albert Einstein College of Medicine in New York. She completed an internal medicine residency and GI fellowship at the Washington University in St. Louis School of Medicine and as the Present-Levison Inflammatory Bowel Diseases Fellow at the Mount Sinai School of Medicine. After fellowship, Dr. Ha joined the faculty as Co-Associate Director of Clinical Research at the Meyerhoff Inflammatory Bowel Disease Center and Associate Fellowship Director for the Division of Gastroenterology and Hepatology at the Johns Hopkins School of Medicine. From there, she joined the Tamar and Vatche Manoukian Division of Digestive Diseases as the Associate Director of Clinical Programs for the Center for Inflammatory Bowel Diseases at the David Geffen School of Medicine prior to moving to Cedars-Sinai. Her clinical research interests focus on the impact of aging on the natural history of inflammatory bowel diseases, particularly with respect to therapeutics, morbidity, and mortality. Dr. Ha is the Director of the IBD Fellowship Program at Cedars-Sinai and has been involved in medical education initiatives locally and nationally.

Miguel Regueiro earned his bachelor’s degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School’s Beth Israel Hospital.

Dr. Regueiro was Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine from 2000 to 2018. There he served as the IBD Clinical Medical Director, Senior Medical Lead of Specialty Medical Homes, was Professor with Tenure, and honored as the UPMC Endowed Chair for Patient Centered Care in Inflammatory Bowel Diseases.

Dr. Regueiro is currently the Chair of the Department of Gastroenterology and Hepatology and Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio. He serves as Medical Co- Chair of Digestive Disease and Surgical Institute Research Governance committee and is Professor of Medicine at the Lerner College of Medicine, Cleveland Clinic.

Dr. Regueiro’s main clinical and research interest is Inflammatory Bowel Diseases with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease. Recently, he has been involved in transformative medicine initiatives and developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. Dr. Regueiro is investigating alternative models of care in population-based health that integrates patients, payers, providers, pharmaceutical industry, and other facets of healthcare delivery around these novel programs.